C10H12N4O3
236.23 g/mol
APIDanger
Didanosine
CAS69655-05-6EC614-994-4
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Didanosine is a synthetic purine nucleoside analog used as an active pharmaceutical ingredient. It is characterized as 2',3'-dideoxy-inosine and is supplied for pharmaceutical manufacturing and research purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 69655-05-6
Related Compounds
Safety Reference
Danger
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H341Suspected of causing genetic defects
H372Causes damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChIKey
BXZVVICBKDXVGW-NKWVEPMBSA-N
SMILES
C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O
Synonyms (66)
- 2DI
- DDI
- Didanosina [INN-Spanish]
- Didanosine (JAN/USP/INN)
- Didanosine for system suitability, European Pharmacopoeia (EP)
- Didanosine, European Pharmacopoeia (EP)
- Didanosine, United States Pharmacopeia (USP)
- Didanosinum [INN-Latin]
- 2',3'-Dideoxy-D-inosine
- 2',3'-Dideoxyinosine
- 2',3'-didesoxyinosin
- DDI and rIFN.alpha.2
- DIDANOSINE [MART.]
- DS-4152 & ddI
- Didanosina
- Didanosine (Standard)
- Didanosine (Videx)
- Didanosine CRS
- Didanosine EC
- Didanosine RS
- Didanosinum
- Dideoxyinosine (DDI)
- Hypoxanthine ddN
- Inosine, 2',3'-dideoxy-
- Intron A & Videx
- LOA & ddI
- Videx
- Videx (TN)
- Videx EC
- Videx(TM)
- ddI & GM-CSF
- ddI & IFN-.alpha.
- ddI & sCD4(rsCD4)
- ddI (Antiviral)
- ddIno
- didanosine